Related Experiment Video
Updated: Aug 14, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Retinoids and interferons in non-melanoma skin cancer
S M Lippman1, D V Kalvakolanu, R Lotan
1University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
Retinoids alone and in combination with interferon-alpha are the best systemic agents to study in the reversal of skin carcinogenesis and in the treatment of advanced squamous cell carcinoma of the skin. This article reviews the major laboratory advances in the mechanistic study of retinoids and interferons alone and in combination. Recent data in several cancer cell lines suggest that retinoic acid can potentiate the interferon signal-transduction pathway. Also reviewed is the current status of clinical studies of systemic retinoids and interferon in (i) skin cancer prevention (as single agents) and (ii) treatment of advanced squamous cell carcinoma (as single agents and in combination). Future clinical studies with translational laboratory correlates are necessary to determine the roles of retinoids and interferons in the prevention and treatment of skin cancer.
Insights
Systemic retinoids and interferon-alpha show promise for skin cancer prevention and treatment. Research indicates retinoic acid may enhance interferon
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Retinoids and interferon-alpha are key systemic agents for skin cancer.
- Understanding their combined mechanisms is crucial for effective treatment.
Purpose of the Study:
- To review laboratory and clinical advances in retinoid and interferon research for skin cancer.
- To explore their potential in skin cancer prevention and treatment.
Main Methods:
- Review of laboratory studies on retinoid and interferon mechanisms.
- Analysis of clinical trial data for skin cancer prevention and treatment.
Main Results:
- Retinoic acid may potentiate interferon signal transduction in cancer cell lines.
- Current clinical data on single-agent and combination therapies are presented.
Conclusions:
- Further clinical studies with laboratory correlates are needed.
- Retinoids and interferons hold potential for skin cancer prevention and treatment.
More Related Videos
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Acne Infection
Inhibitors of Viral Protein Synthesis